ArticleMedical oncology (Northwood, London, England)2021

Treating MCF7 breast cancer cell with proteasome inhibitor Bortezomib restores apoptotic factors and sensitizes cell to Docetaxel.

Kayhan Mehdizadeh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.